DE69905143D1 - Anti-tumor-mittel - Google Patents

Anti-tumor-mittel

Info

Publication number
DE69905143D1
DE69905143D1 DE69905143T DE69905143T DE69905143D1 DE 69905143 D1 DE69905143 D1 DE 69905143D1 DE 69905143 T DE69905143 T DE 69905143T DE 69905143 T DE69905143 T DE 69905143T DE 69905143 D1 DE69905143 D1 DE 69905143D1
Authority
DE
Germany
Prior art keywords
alkyl
hydrogen
tumor agents
benzensulphonyloxy
alkynylimino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69905143T
Other languages
English (en)
Other versions
DE69905143T2 (de
Inventor
Francis Thomas Boyle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE69905143D1 publication Critical patent/DE69905143D1/de
Application granted granted Critical
Publication of DE69905143T2 publication Critical patent/DE69905143T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE69905143T 1998-03-20 1999-03-16 Anti-tumor-mittel Expired - Fee Related DE69905143T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9805868.8A GB9805868D0 (en) 1998-03-20 1998-03-20 Anti-tumour agents
PCT/GB1999/000786 WO1999048860A1 (en) 1998-03-20 1999-03-16 Anti-tumour agents

Publications (2)

Publication Number Publication Date
DE69905143D1 true DE69905143D1 (de) 2003-03-06
DE69905143T2 DE69905143T2 (de) 2003-11-20

Family

ID=10828860

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69905143T Expired - Fee Related DE69905143T2 (de) 1998-03-20 1999-03-16 Anti-tumor-mittel

Country Status (19)

Country Link
US (1) US6472435B1 (de)
EP (1) EP1064257B1 (de)
JP (1) JP2002507592A (de)
KR (1) KR20010042056A (de)
CN (1) CN1178900C (de)
AT (1) ATE231836T1 (de)
AU (1) AU746715B2 (de)
BR (1) BR9908934A (de)
CA (1) CA2319335A1 (de)
DE (1) DE69905143T2 (de)
DK (1) DK1064257T3 (de)
ES (1) ES2192036T3 (de)
GB (1) GB9805868D0 (de)
IL (1) IL138590A (de)
NO (1) NO20004663L (de)
NZ (1) NZ506011A (de)
PT (1) PT1064257E (de)
WO (1) WO1999048860A1 (de)
ZA (1) ZA200004386B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9805866D0 (en) 1998-03-20 1998-05-13 Zeneca Ltd Anti-tumour agents
US6413533B1 (en) * 1998-05-07 2002-07-02 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
US20060099712A1 (en) * 2004-11-08 2006-05-11 Eastman Kodak Company Correlation of anti-cancer activity of dyes with redox potentials
AU2006222941C1 (en) * 2005-03-11 2011-06-16 Medical Instill Technologies, Inc. Sterile de-molding apparatus and method
US20110039943A1 (en) * 2005-03-14 2011-02-17 Robert Alonso Methods for treating skin disorders with topical nitrogen mustard compositions
US7872050B2 (en) * 2005-03-14 2011-01-18 Yaupon Therapeutics Inc. Stabilized compositions of volatile alkylating agents and methods of using thereof
US8501818B2 (en) * 2005-03-14 2013-08-06 Ceptaris Therapeutics, Inc. Stabilized compositions of alkylating agents and methods of using same
US20110104250A1 (en) * 2007-09-07 2011-05-05 Mccarley Robin L Redox-gated Liposomes
DK3494960T3 (da) 2008-03-27 2021-01-25 Helsinn Healthcare Sa Stabiliserede sammensætninger af alkyleringsmidler og fremgangsmåder til anvendelse af samme
KR101006166B1 (ko) * 2008-12-10 2011-01-07 건국대학교 산학협력단 지하철 역 선로에 설치되는 자기성 분진 수거 장치 및 그 방법
BR112013030370A2 (pt) 2011-05-26 2017-08-08 Apex Therapeutics Inc compostos de quinona para tratamento de doenças mediadas por ape1
WO2012167122A1 (en) 2011-06-03 2012-12-06 Indiana University Research And Technology Corporation Compounds, compositions and methods for treating oxidative dna damage disorders
WO2018053313A1 (en) 2016-09-19 2018-03-22 Memorial Sloan-Kettering Cancer Center Adenosine analogs as methyltransferase inhibitors for treating cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002677B1 (de) 1977-12-02 1982-10-13 Takeda Chemical Industries, Ltd. Glucosamin-peptid-Derivate und ihre pharmazeutischen Zusammensetzungen
JPS58177934A (ja) 1982-04-13 1983-10-18 Takeda Chem Ind Ltd ベンゾキノン誘導体
NZ240785A (en) * 1991-11-28 1995-08-28 Cancer Res Campaign Tech Substituted nitro aniline derivatives and medicaments
GB9805866D0 (en) 1998-03-20 1998-05-13 Zeneca Ltd Anti-tumour agents

Also Published As

Publication number Publication date
CN1293656A (zh) 2001-05-02
US6472435B1 (en) 2002-10-29
ES2192036T3 (es) 2003-09-16
IL138590A0 (en) 2001-10-31
DK1064257T3 (da) 2003-05-26
NO20004663D0 (no) 2000-09-19
EP1064257A1 (de) 2001-01-03
AU746715B2 (en) 2002-05-02
EP1064257B1 (de) 2003-01-29
ZA200004386B (en) 2002-01-30
NO20004663L (no) 2000-11-13
BR9908934A (pt) 2005-10-25
WO1999048860A1 (en) 1999-09-30
IL138590A (en) 2004-08-31
KR20010042056A (ko) 2001-05-25
JP2002507592A (ja) 2002-03-12
CA2319335A1 (en) 1999-09-30
AU2846799A (en) 1999-10-18
GB9805868D0 (en) 1998-05-13
NZ506011A (en) 2002-10-25
PT1064257E (pt) 2003-06-30
CN1178900C (zh) 2004-12-08
DE69905143T2 (de) 2003-11-20
ATE231836T1 (de) 2003-02-15

Similar Documents

Publication Publication Date Title
DE69905143T2 (de) Anti-tumor-mittel
HUP0301690A2 (hu) Szinergikus eljárások és készítmények rák kezelésére
HUP0102471A2 (hu) 4-Benzil-piperidin alkilszulfoxid heterociklusok és használatuk altípus-szelektív NMDA antagonistaként és ezeket tartalmazó gyógyszerkészítmények
HK1068334A1 (en) Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments
DE69831499D1 (de) Inhibitoren des nukleosid-metabolismus
NZ334954A (en) Substituted heterocycles as anti-tumor agents
MY139612A (en) Benzoxazine derivatives as 5-th6 modulators and uses thereof
MY118004A (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
MXPA05010651A (es) Compuestos de pirazol.
ES455741A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,3-bencenodimetanol.
IL114968A (en) 1,4-dihydropyridine compounds and pharmaceutical compositions containing them
BR9604907A (pt) Derivados de nucleosideos hamocarbociclico de pirimidinodiona substituida aniviral e métodos de preparo dos mesmos e composiçoes contendo tais derivados como principios ativos
ZA995321B (en) Indan-1-Ol compounds, a process for their preparation and pharmaceutical compositions containing them.
HUP0402544A2 (hu) Kompozíció elektrolit oldathoz és eljárás az előállítására
DE69905142T2 (de) Anti-tumor-mittel
PT944618E (pt) Novos compostos de n-benzenossulfonilo-1-prolina processo de preparacao e utilizacao em terapia
WO2004110379A3 (en) A1 adenosine receptor antagonists
KR970706280A (ko) 5-HT1A 길항제로서의 비사이클릭 카복스아미드(Bicyclic carboxamides as 5-HT1 antagonists)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee